Latest filing published 05 Jun 2026 for XSpray Pharma AB (publ), €45k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Anders Lennart Bladh, Ribbskottet: trading record in brief
Anders Lennart Bladh, Ribbskottet (board member) discloses dealings in XSpray Pharma AB (publ) to Finansinspektionen. The record holds 6 filings, for trades running from 9 September 2025 to 3 June 2026.
No open-market sale appears; the market trades are 2 purchases worth €90k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2026 alone, the filings show 2 purchases and no sales.
The newest entry dates from 5 June 2026: an open-market purchase of €45k, in XSpray Pharma AB (publ). Typically, a trade is published a median of 2 days after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Anders Lennart Bladh, Ribbskottet
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 19,999 shares@ SEK 24.601.9% of flowAktieISIN SE0009973563FI:A003Z630-1Canonical exit: 1 Sept 2026 (T+90)
- 1,818 shares@ SEK 20.000.1% of flowBTA (betald tecknad aktie)ISIN SE0028355099FI:A003X724-1
- 475,764 shares@ SEK 20.0037.1% of flowBTA (betald tecknad aktie)ISIN SE0028355099FI:A003X725-1
- 430,000 shares@ SEK 35.0057.6% of flowBTA (betald tecknad aktie)ISIN SE0026140865FI:A003S241-1
- 23,821 shares@ SEK 35.003.2% of flowBTA (betald tecknad aktie)ISIN SE0026140865FI:A003S242-2
5 of 5 declarations